This study demonstrated that PTH levels ≥166 ng/L and age ≥65 years were associated with an increased risk of IHD, while statin use is associated with a decreased risk of IHD in individuals with CKD stage 3–5ND. This evidence concerns the gene PTH and myocardial ischemia.